Keating Financial Advisory Services’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Keating Financial Advisory Services's TRAX Position: Q3 2026 in Review
Keating Financial Advisory Services opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 1 share worth $35. The stake represents ﹤0.01% of the portfolio and ranks #2535 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Keating Financial Advisory Services held 1 share of First Tracks Biotherapeutics worth $35 as of Q3 2026.
- First Tracks Biotherapeutics was a new Keating Financial Advisory Services position in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q3 2026, its #2535 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Keating Financial Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.